Your browser doesn't support javascript.
loading
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.
Jo, Jae-Cheol; Jeon, Youngwoo; Kim, DaJung; Yang, Deok-Hwan; Lee, Won Sik; Choi, Yoon Seok; Yi, Jun Ho; Yoon, Dok Hyun; Kong, Jee Hyun; Choe, Jung-Yoon; Kim, SungHyun; Ahn, KeumYoung; Park, TaeHong; Ju, Hana; Kwon, Soonbum; Cho, Seok-Goo.
Affiliation
  • Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
  • Jeon Y; Department of Hematology, Lymphoma and Cell Therapy-Research Center, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim D; Department of Internal Medicine, Kosin University College of Medicine, Kosin University, Seo-gu, Busan, Republic of Korea.
  • Yang DH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun-gun, Jeollanam-do, Republic of Korea.
  • Lee WS; Department of Internal Medicine, Hemato-oncology, Inje University Busan Paik Hospital, Busangjin-gu, Busan, Republic of Korea.
  • Choi YS; Department of Hematology-Oncology, Ajou University Hospital, Suwon, Gyeonggi-do, Republic of Korea.
  • Yi JH; Department of Internal Medicine, Division of Hematology and Oncology, Chung-ang University Hospital, Dongjak-gu, Seoul, Republic of Korea.
  • Yoon DH; Department of Oncology, Asan Medical Center, Songpa-gu, Seoul, Republic of Korea.
  • Kong JH; Department of Hematology-Oncology, Division of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Gangwon-do, Republic of Korea.
  • Choe JY; Department of Internal Medicine, Daegu Catholic University School of Medicine, Nam-gu, Daegu, Republic of Korea.
  • Kim S; Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Korea.
  • Ahn K; Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Korea.
  • Park T; Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Korea.
  • Ju H; Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Korea.
  • Kwon S; Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Korea.
  • Cho SG; Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seocho-gu, Seoul, Republic of Korea.
Expert Opin Biol Ther ; 23(8): 737-747, 2023.
Article in En | MEDLINE | ID: mdl-36757373
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Lymphoma, Non-Hodgkin / Leukemia, Lymphocytic, Chronic, B-Cell / Granulomatosis with Polyangiitis / Biosimilar Pharmaceuticals Type of study: Evaluation_studies / Screening_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Lymphoma, Non-Hodgkin / Leukemia, Lymphocytic, Chronic, B-Cell / Granulomatosis with Polyangiitis / Biosimilar Pharmaceuticals Type of study: Evaluation_studies / Screening_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2023 Document type: Article Country of publication: